CLDICalidi Biotherapeutics, Inc.

NYSE www.calidibio.com


$ 1.71 $ 1.55 (980.23 %)    

Monday, 15-Jul-2024 13:57:41 EDT
QQQ $ 496.32 $ -0.42 (-0.08 %)
DIA $ 402.79 $ 0.19 (0.05 %)
SPY $ 561.93 $ -0.24 (-0.04 %)
TLT $ 92.90 $ -0.06 (-0.06 %)
GLD $ 223.99 $ 0.57 (0.26 %)
$ 0.1583
$ 1.61
$ 1.73 x 500
$ 0.00 x 0
$ 1.42 - $ 2.06
$ 0.14 - $ 13.79
1,520,945
na
562,788
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-21-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-calidi-biotherapeutics-cldi-shares-are-trading-lower

Calidi Biotherapeutics shares are trading lower by 14.3% during Monday's session. The company announced a 1-for-10 reverse ...

Core News & Articles

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Calidi Biotherapeutics (AMEX:CLDI) with a Buy rating and ann...

 why-calidi-biotherapeutics-is-moving-higher-monday

Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.

Core News & Articles

Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...

Core News & Articles

Calidi Biotherapeutics Inc. (NYSE:CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation ...

 why-calidi-biotherapeutics-cldi-stock-is-getting-hammered

Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreem...